California State Teachers Retirement System (CalSTRS)’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$594K Buy
112,316
+104,260
+1,294% +$602K ﹤0.01% 2000
2025
Q4
$43.3K Buy
8,056
+662
+9% +$3.06K ﹤0.01% 2313
2025
Q3
$25.9K Buy
7,394
+4
+0.1% +$13 ﹤0.01% 2449
2025
Q2
$19.2K Hold
7,390
﹤0.01% 2513
2025
Q1
$14K Hold
7,390
﹤0.01% 2652
2024
Q4
$10.7K Hold
7,390
﹤0.01% 2839
2024
Q3
$13.6K Hold
7,390
﹤0.01% 2772
2024
Q2
$7.39K Sell
7,390
-1,786
-19% -$2.61K ﹤0.01% 2985
2024
Q1
$18.2K Sell
9,176
-5,845
-39% -$10.1K ﹤0.01% 2762
2023
Q4
$23.4K Sell
15,021
-72,268
-83% -$125K ﹤0.01% 2866
2023
Q3
$172K Sell
87,289
-9,835
-10% -$24.3K ﹤0.01% 2533
2023
Q2
$309K Buy
97,124
+30,732
+46% +$96.5K ﹤0.01% 2472
2023
Q1
$217K Buy
+66,392
New +$261K ﹤0.01% 2562

Other funds holding CMPX

California State Teachers Retirement System (CalSTRS)'s CMPX Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Compass Therapeutics (CMPX) stake by 1,294% in Q1 2026, buying an estimated $602K and bringing the position to 112,316 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

California State Teachers Retirement System (CalSTRS) first reported a position in CMPX in Q1 2023 and has held it in 13 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 112,316 shares of Compass Therapeutics worth $594K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 104,260 Compass Therapeutics shares in Q1 2026, an estimated $602K.
  • Compass Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2000 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Compass Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.